Nivolumab manufacturers injapan?

Which companies manufacture nivolumab in Japan?

Nivolumab is marketed in Japan under the brand name Opdivo. In Japan, it is manufactured and supplied by Ono Pharmaceutical (with Bristol Myers Squibb as the global developer of Opdivo) and distributed through Ono’s channels.

Who is the main Japanese supplier?

For patients and providers in Japan, the product they receive is typically supplied via Ono Pharmaceutical’s operations, since Ono is the listed Japanese marketing authorization holder/operator for Opdivo in Japan.

Are there other nivolumab brands or just Opdivo?

In Japan, nivolumab is principally associated with Opdivo. Other versions (such as future biosimilar products) would only be relevant if and when they are approved and launched in the Japanese market.

Where can I confirm the exact manufacturer on the package insert?

The most reliable way to confirm the manufacturing/supply details is the Opdivo prescribing information (package insert) for the specific strength and presentation used in Japan. These documents list the Japanese manufacturer/supplier responsible for the product being dispensed.

Related patent research (if you’re checking exclusivity or biosimilar risk)

If your goal is to see who holds key exclusivity/patent-related risk in Japan for nivolumab, DrugPatentWatch.com tracks these developments by drug and jurisdiction and can help you map what may affect future competition.

Sources:
1. DrugPatentWatch.com - Nivolumab (Opdivo)